Apr 07, 2020 / 12:00PM GMT
Operator
Greetings and welcome to X4 Pharmaceuticals 2020 Analyst Day Webinar.
(Operator Instructions)
As a reminder, this webinar call is being recorded. It is now my pleasure to introduce Adam Mostafa, Chief Financial Officer of X4 Pharmaceuticals. You may begin.
Adam Mostafa - X4 Pharmaceuticals, Inc. - CFO
Thank you, operator, and good morning everyone. Thank you so much for joining us in our webinar, A Deep Dive into WHIM Syndrome.
Before we begin, I would like to remind everyone that on today's call we will be making forward-looking statements regarding our regulatory and product development plans as well as our research activities. These statements subject to risk and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in our most recent Form 10-K on file with the SEC.
On the webinar today, we will start with the high level overview of X4, why we're focused on rare diseases resulting from dysfunctional signaling of the CXCR4 receptor and then provide some
X4 Pharmaceuticals Inc Virtual Analyst Day - A Deep Dive into WHIM Syndrome Transcript
Feb 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers